Trisha Wise-Draper
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Trisha Wise-Draper sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Trisha Wise-Draper: 6 sponsored US clinical trials, none currently recruiting.
Trisha Wise-Draper sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Head and Neck Cancer, with 3 trials.
Upper-quartile sponsor footprint
Trisha Wise-Draper sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Amivantamab in Adenoid Cystic Carcinoma
NCT05074940
Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC
NCT04313504
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
NCT04414540
Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
NCT03355560
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
NCT02641093
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT03691714
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 6 |
Therapeutic Areas
How the Trisha Wise-Draper early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 1 completed (17%).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Head and Neck Cancer (3 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Trisha Wise-Draper: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Trisha Wise-Draper sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Trisha Wise-Draper page
6 registered trials is a research-attention snapshot, not an endorsement of Trisha Wise-Draper or any single study.
- None of Trisha Wise-Draper's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Head and Neck Cancer is the condition Trisha Wise-Draper studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Head and Neck Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Trisha Wise-Draper pipeline card: 6 registered trials from official public datasets.Report a data error.